1. Oral cyclophosphamide (CTX) for hormone refractory prostate cancer (HRPC) [abstract 646];Abele;Proc Am Soc Clin Oncol,1995
2. Epirubicin plus cisplatin in hormone-refractory prostate cancer [abstract 753];Aitken;Proc Am Soc Clin Oncol,1993
3. Preliminary results of a phase II trial of estramustine and vinblastine for patients with progressive hormone-refractory prostate cancer [abstract 1111];Amato;Proc Am Assoc Cancer Res,1991
4. Treatment of hormone-refractory prostate adenocarcinoma (HRPA) with estramustine and vinblastine (EV) chemotherapy [abstract 745];Atiq;Proc Am Soc Clin Oncol,1994
5. High dose intravenous 5-fluorouracil (5FU) and oral leucovorin (LV) for hormone refractory advanced prostate cancer (APC) [abstract 734];Atkins;Proc Am Soc Clin Oncol,1993